147 related articles for article (PubMed ID: 18421499)
21. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
[TBL] [Abstract][Full Text] [Related]
22. CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results.
Li X; Fan W; Zhang L; Zhao M; Huang Z; Li W; Gu Y; Gao F; Huang J; Li C; Zhang F; Wu P
Cancer; 2011 Nov; 117(22):5182-8. PubMed ID: 21523760
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
Marshall FF
J Urol; 2005 Nov; 174(5):1782. PubMed ID: 16217284
[No Abstract] [Full Text] [Related]
24. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer.
King J; Glenn D; Clark W; Zhao J; Steinke K; Clingan P; Morris DL
Br J Surg; 2004 Feb; 91(2):217-23. PubMed ID: 14760671
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results.
Su Li; Jarrett TW; Chan DY; Kavoussi LR; Solomon SB
Urology; 2003 Apr; 61(4 Suppl 1):26-33. PubMed ID: 12657358
[TBL] [Abstract][Full Text] [Related]
28. Painful pelvic recurrence of rectal cancer: percutaneous radiofrequency ablation treatment.
Pusceddu C; Sotgia B; Melis L; Fele RM; Meloni GB
Abdom Imaging; 2013 Dec; 38(6):1225-33. PubMed ID: 23736888
[TBL] [Abstract][Full Text] [Related]
29. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy.
McBride JF; Atwell TD; Charboneau WJ; Young WF; Wass TC; Callstrom MR
J Vasc Interv Radiol; 2011 Sep; 22(9):1263-70. PubMed ID: 21856504
[TBL] [Abstract][Full Text] [Related]
30. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous ultrasound-guided radiofrequency ablation for kidney tumors in patients with surgical risk.
Salagierski M; Salagierski M; Salagierska-Barwińska A; Sosnowski M
Int J Urol; 2006 Nov; 13(11):1375-9. PubMed ID: 17083386
[TBL] [Abstract][Full Text] [Related]
32. [Radiofrequency ablation of malignant liver tumors].
Nielsen DT; Laursen HB; Rokkjaer M; Astrup LB
Ugeskr Laeger; 2002 Sep; 164(40):4642-5. PubMed ID: 12380115
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
Schneider T; Puderbach M; Kunz J; Bischof A; Giesel FL; Dienemann H; Herth FJ; Schnabel PA; Safi S; Hoffmann H; Heussel CP
Respiration; 2012; 84(6):501-8. PubMed ID: 23037897
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses.
Felker ER; Lee-Felker SA; Alpern L; Lu D; Raman SS
AJR Am J Roentgenol; 2013 Nov; 201(5):1029-35. PubMed ID: 24147473
[TBL] [Abstract][Full Text] [Related]
35. Imaging-guided radiofrequency ablation of cystic renal neoplasms.
Allen BC; Chen MY; Childs DD; Zagoria RJ
AJR Am J Roentgenol; 2013 Jun; 200(6):1365-9. PubMed ID: 23701077
[TBL] [Abstract][Full Text] [Related]
36. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
[TBL] [Abstract][Full Text] [Related]
37. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
[TBL] [Abstract][Full Text] [Related]
38. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of radiofrequency ablation in the treatment of small functional adrenal neoplasms.
Mendiratta-Lala M; Brennan DD; Brook OR; Faintuch S; Mowschenson PM; Sheiman RG; Goldberg SN
Radiology; 2011 Jan; 258(1):308-16. PubMed ID: 20980448
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P
AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
